Technical Analysis for ANIK - Anika Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 30.48 1.74% 0.52
ANIK closed up 1.74 percent on Monday, March 18, 2019, on 1.21 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical ANIK trend table...

Date Alert Name Type % Chg
Mar 18 1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Mar 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Mar 18 Multiple of Ten Bullish Other 0.00%
Mar 18 Wide Bands Range Expansion 0.00%
Mar 18 Up 3 Days in a Row Strength 0.00%
Mar 18 Oversold Stochastic Weakness 0.00%
Mar 15 Pocket Pivot Bullish Swing Setup 1.74%
Mar 15 Volume Surge Other 1.74%
Mar 15 Multiple of Ten Bearish Other 1.74%
Mar 15 Wide Bands Range Expansion 1.74%

Older signals for ANIK ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Anika Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company's products include ORTHOVISC, ORTHOVISC mini, and MONOVISC for the treatment of osteoarthritis of the knee and various other joints; Hyalofast, a biodegradable support for human bone marrow mesenchymal stem cells that is used in connection with soft tissue regeneration; Hyalonect, a woven gauze used as a graft wrap; Hyaloss, HYAFF fibers used to mix blood/bone grafts to form a paste for bone regeneration; and Hyaloglide, an ACP gel used in tenolysis treatment. It also provides wound care products that comprise Hyalomatrix and Hyalofill, for treatment of complex wounds, such as burns and ulcers; and Hyalograft 3D and Laserskin scaffolds for use in connection with the regeneration of skin, as well as ELEVESS, an aesthetic dermatology product for facial wrinkles and scar remediation. In addition, the company offers AMVISC, AMVISC Plus, STAARVISC-II, Optivisc, AnikaVisc, and AnikaVisc Plus that are injectable HA products used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. Further, it provides Hyalobarrier, a post-operative adhesion barrier; INCERT, a HA product for the prevention of spinal post-surgical adhesions; and Merogel, a woven fleece nasal packing, as well as Merogel Injectable, a viscous hydrogel. Additionally, the company offers HYVISC, an injectable HA product used for the treatment of joint dysfunction in horses. Anika Therapeutics, Inc. markets its products directly, as well as through a network of distributors in the United States, Europe, and internationally. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Medicine Stem Cells Osteoarthritis Therapeutic Products Cataract Scar Burns Treatment Of Osteoarthritis Bone Grafting Therapeutic Glycosaminoglycans Hyaluronic Acid Oral And Maxillofacial Surgery Wound Care Products
Is ANIK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 53.08
52 Week Low 28.54
Average Volume 173,036
200-Day Moving Average 37.1823
50-Day Moving Average 35.065
20-Day Moving Average 32.797
10-Day Moving Average 30.537
Average True Range 1.3623
ADX 43.73
+DI 11.9243
-DI 27.964
Chandelier Exit (Long, 3 ATRs ) 36.6231
Chandelier Exit (Short, 3 ATRs ) 33.1369
Upper Bollinger Band 39.4817
Lower Bollinger Band 26.1123
Percent B (%b) 0.33
BandWidth 40.764094
MACD Line -1.743
MACD Signal Line -1.5376
MACD Histogram -0.2053
Fundamentals Value
Market Cap 446.78 Million
Num Shares 14.7 Million
EPS 2.25
Price-to-Earnings (P/E) Ratio 13.55
Price-to-Sales 7.22
Price-to-Book 3.29
PEG Ratio 2.68
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.39
Resistance 3 (R3) 32.31 31.61 32.07
Resistance 2 (R2) 31.61 31.12 31.64 31.96
Resistance 1 (R1) 31.04 30.82 31.33 31.12 31.86
Pivot Point 30.34 30.34 30.48 30.37 30.34
Support 1 (S1) 29.77 29.85 30.06 29.85 29.10
Support 2 (S2) 29.07 29.55 29.10 29.00
Support 3 (S3) 28.50 29.07 28.89
Support 4 (S4) 28.58